| P50 | author | Keith M Diaz | Q84372625 |
| | Meredith Kilgore | Q88244081 |
| | Paul Muntner | Q90572515 |
| | Daichi Shimbo | Q98526959 |
| | Shia T Kent | Q114414594 |
| | Suzanne Oparil | Q30029225 |
| P2093 | author name string | Lei Huang | |
| P2860 | cites work | 2007 Guidelines for the Management of Arterial Hypertension | Q56970780 |
| | Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization | Q81651947 |
| | Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results and seventh report of the joint national committee on prevention, detection, eval | Q83363265 |
| | Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies | Q24658205 |
| | The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 |
| | Heart disease and stroke statistics--2014 update: a report from the American Heart Association | Q29547691 |
| | 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) | Q29617334 |
| | Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | Q29618529 |
| | Generic alendronate use among Medicare beneficiaries: are Part D data complete? | Q30576763 |
| | A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. | Q34176994 |
| | 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension | Q34274434 |
| | Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr | Q34628291 |
| | Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis | Q35020192 |
| | Hypertension control among newly treated patients before and after publication of the main ALLHAT results and JNC 7 guidelines | Q35983579 |
| | Initial monotherapy and combination therapy and hypertension control the first year | Q36184174 |
| | Antihypertensive prescribing practices: impact of the antihypertensive and lipid-lowering treatment to prevent heart attack trial | Q36684797 |
| | Validity of administrative database coding for kidney disease: a systematic review | Q37823965 |
| | ACE Inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008. | Q44239004 |
| | Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. | Q44327990 |
| | Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial | Q44412916 |
| | Treatment of isolated systolic hypertension: the SHELL study results | Q44521967 |
| | Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients | Q46217490 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e105888 | |
| P577 | publication date | 2014-08-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Antihypertensive medication classes used among medicare beneficiaries initiating treatment in 2007-2010 | |
| P478 | volume | 9 | |